Global Whole Exome Sequencing Market
Sizing, Segmentation, & Growth Forecast (2025-2030)
Last updated: August 2026
Report Scope: The downloadable datasheet contains market sizes in USD for the period 2025-30.
Market Breakdown: Sizes and growth rates are broken down by geography and market segment (see below for details).
1. Summary
The Global Whole Exome Sequencing Market was valued at $2.8 bn. in 2025. During the forecast period 2025-2030, it is expected to grow at 18.5% CAGR, to an estimated market size of $6.4 bn. in 2030. A detailed breakdown by segment and geography is provided in the downloadable datasheet.
2. Market Definition
The Whole Exome Sequencing (WES) market comprises the technologies, reagents, and services used to sequence the protein-coding regions (exons) of the genome. While the exome represents only 1-2% of the human genome, it contains approximately 85% of known disease-causing mutations, making WES a cost-effective alternative to whole-genome sequencing for clinical diagnostics, rare disease identification, and oncology research.
3. Trends & Demand Drivers
Several key trends are expected to significantly impact the Whole Exome Sequencing Market in the period 2025-30:
- Significant cost reduction in sequencing technologies has dropped per-exome costs to below USD 350, making it accessible for routine clinical use.
- The integration of Artificial Intelligence and machine learning is accelerating the interpretation of complex genomic data and identification of pathogenic variants.
- A major shift is occurring from research-based applications to routine clinical diagnostics, particularly as a first-tier test for undiagnosed pediatric rare diseases.
- Global government initiatives and population-scale genomics projects, such as the UK Biobank and Genome India, are driving massive demand for sequencing data.
- Rising demand for personalized medicine is fueling the use of WES to identify somatic mutations for targeted oncology therapies and immunotherapy response prediction.
- The market is seeing a transition toward high-throughput platforms and cloud-based bioinformatics to handle the increasing volume of genomic data.
- Increased outsourcing to specialized sequencing service providers is helping hospitals and research institutes bypass high infrastructure and personnel costs.
4. Market Breakdown
The downloadable datasheet breaks market sizes and growth rates (CAGRs) down into the following geographies and segments:
Geographies
- North America
- Europe
- Asia-Pacific
- Rest of World
Segments
- Services
- Kits & Reagents
- Systems & Instruments